Jelinek MJ, Foster NR, Zoroufy AJ, Schwartz GK, et al. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol 2021;114:105171.
PMID: 33513474